Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

St. Jude researchers decipher structure, activity of enzyme key to biochemical pathways of life

27.03.2003


Finding how E1 enzyme juggles three jobs should lead to critical insights into the control of cellular functions at the heart of health and disease



Scientists at St. Jude Children’s Research Hospital have discovered how a single enzyme called E1 performs a rapid-fire, three-part chemical makeover of a protein that helps control some of the most fundamental biochemical processes of the human cell. The enzyme uses two different parts of its own structure to juggle four different molecules as it completes three different reactions.

This rare ability of a single enzyme to carry out three different chemical reactions by itself is at the heart of the role E1 plays in modifying NEDD8, which is part of a family of proteins called ubiquitin-like proteins. E1 proteins are a family of molecules called activating enzymes.


These enzymes coordinate the activity of different ubiquitin-like proteins.

The cell uses ubiquitin-like proteins such as NEDD8 to trigger special molecules that act as on switches for a variety of biochemical pathways, according to Brenda Schulman, Ph.D., an assistant member of the St. Jude Departments of Structural Biology, Genetics and Tumor Cell Biology.

The pathways switched on by ubiquitin-like proteins include vital activities, such as immune responses and cell division, she said. Schulman is the senior author of a report appearing in the March 20 issue of Nature on the structure and function of the E1 activating enzyme for NEDD8.

"The cell uses E1 activating enzymes to keep a tight rein on all of the various biochemical pathways it must activate," Schulman said. "Otherwise the cell would be chaotic and wouldn’t be able to perform the tasks it is supposed to do in the body."

Each type of E1 activating enzyme coordinates a specific function to make sure it occurs at precisely the right time, she says.

The complex series of reactions that control each function begins when a specific E1 activating enzyme combines an ubiquitin-like protein such as NEDD8 to an "escort" molecule.

The escort brings the ubiquitin-like protein to its pre-assigned target molecule. When the ubiquitin-like protein chemically modifies this molecule, the molecule triggers a specific cellular activity, such as cell division.

The discovery of the structure of the E1 activating enzyme for NEDD8 helps explain the critical steps by which E1 links NEDD8 to its E2 escort.

"Now that we know exactly what the E1 for NEDD8 looks like and how it works, we can start to understand how the cell controls its extraordinarily complex command and control systems," Schulman said. "We’ll start to understand how the cell gets through the day doing its jobs and keeping us healthy--or making us ill when its command and control systems get disrupted."

For example, the influenza virus hijacks one of the ubiquitin-like proteins so it does not undergo its normal activation by an E1 enzyme.

This hijacking helps the virus hide from the surveillance system set up by the immune system to track infections.

"The more we learn about how these pathways are controlled, the more likely we’ll understand how to fix them when they get disrupted and cause a wide variety of diseases," Schulman said.

Schulman and her colleagues obtained the information that let them create a picture of the E1 structure using a technique called X-ray crystallography. In this technique, the proteins are first crystallized to immobilize them, and then X-rays are directed at the protein crystal.

The pattern formed by the x-rays as they bounce off the protein crystal is then translated into a picture of the molecule.

Other authors of the paper include Helen Walden, Ph.D. and Michael S. Podgorski, both of St. Jude.


The work was supported by ALSAC, the National Cancer Institute Cancer Center (CORE) and a Pew Scholar in Biomedical Science Award to ’Schulman.

St. Jude Children’s Research Hospital
St. Jude Children’s Research Hospital, in Memphis, Tennessee, was founded by the late entertainer Danny Thomas. The hospital is an internationally recognized biomedical research center dedicated to finding cures for catastrophic diseases of childhood. The hospital’s work is supported through funds raised by ALSAC. ALSAC covers all costs not covered by insurance for medical treatment rendered at St. Jude Children’s Research Hospital. Families without insurance are never asked to pay. For more information, please visit http://.

Bonnie Cameron | EurekAlert!
Further information:
http://www.stjude.org

More articles from Life Sciences:

nachricht Topologische Quantenchemie
21.07.2017 | Max-Planck-Institut für Chemische Physik fester Stoffe

nachricht Topological Quantum Chemistry
21.07.2017 | Max-Planck-Institut für Chemische Physik fester Stoffe

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

Ultrathin device harvests electricity from human motion

24.07.2017 | Power and Electrical Engineering

Scientists announce the quest for high-index materials

24.07.2017 | Materials Sciences

ADIR Project: Lasers Recover Valuable Materials

24.07.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>